Heritage Wealth Advisors Dbv Technologies S.A. Transaction History

Heritage Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	BUY	$5.32 - $6.53 $26,600 - $32,650	5,000 Added 500.0%	6,000 $32,000
Q2 2021 Jul 27, 2021	SELL	$5.32 - $6.53 $26,600 - $32,650	-5,000 Reduced 83.33%	1,000 $3,000
Q1 2021 Apr 27, 2021	BUY	$2.75 - $6.57 $13,750 - $32,850	5,000 Added 500.0%	6,000 $31,000
Q4 2020 Feb 01, 2021	BUY	$1.38 - $3.01 $1,380 - $3,010	1,000 New	1,000 $3,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $88.3M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Advisors with notifications on news.